198 related articles for article (PubMed ID: 31747477)
1. Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis.
Greverath LM; Leicht E; Wald de Chamorro N; Wilde AB; Steinhagen LM; Lieb C; Schmelzle M; Chopra S; Shibolet O; Fischer J; Berg T; Tacke F; Müller T
Hepatol Res; 2020 Mar; 50(3):321-329. PubMed ID: 31747477
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Wilde AB; Greverath LM; Steinhagen LM; de Chamorro NW; Leicht E; Fischer J; Herta T; Berg T; Preuss B; Klein R; Tacke F; Müller T
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160133
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
[TBL] [Abstract][Full Text] [Related]
4. Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis.
Dyson JK; Blain A; Foster Shirley MD; Hudson M; Rushton S; Jeffreys Jones DE
JHEP Rep; 2021 Feb; 3(1):100202. PubMed ID: 33474546
[TBL] [Abstract][Full Text] [Related]
5. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with primary biliary cirrhosis.
Tsuboi H; Ohira H; Asashima H; Tsuzuki S; Iizuka M; Matsuo N; Kondo Y; Matsumoto I; Sumida T
Hepatol Res; 2014 Dec; 44(14):E471-9. PubMed ID: 24750585
[TBL] [Abstract][Full Text] [Related]
6. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
[TBL] [Abstract][Full Text] [Related]
7. Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan.
Tanaka A; Mori M; Matsumoto K; Ohira H; Tazuma S; Takikawa H
Hepatol Res; 2019 Aug; 49(8):881-889. PubMed ID: 30932290
[TBL] [Abstract][Full Text] [Related]
8. Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases.
Laursen TL; Bossen L; Pihl R; Troldborg A; Sandahl TD; Hansen AG; Folserass T; Vesterhus M; Grønbæk H; Thiel S
J Clin Transl Hepatol; 2022 Oct; 10(5):796-802. PubMed ID: 36304505
[TBL] [Abstract][Full Text] [Related]
9. Chronic cholestatic diseases.
Poupon R; Chazouillères O; Poupon RE
J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes.
Mayer C; Preuss B; Grottenthaler J; Berg C; Klein R
Front Immunol; 2020; 11():1151. PubMed ID: 32695096
[No Abstract] [Full Text] [Related]
11. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
Mattner J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
[TBL] [Abstract][Full Text] [Related]
12. Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis.
Lammert C; Juran BD; Schlicht E; Xie X; Atkinson EJ; de Andrade M; Lazaridis KN
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1562-8. PubMed ID: 24440215
[TBL] [Abstract][Full Text] [Related]
13. Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Adam L; Zoldan K; Hofmann M; Schultheiss M; Bettinger D; Neumann-Haefelin C; Thimme R; Böettler T
Hepatol Commun; 2018 Sep; 2(9):1051-1063. PubMed ID: 30202820
[TBL] [Abstract][Full Text] [Related]
14. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
15. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.
Wunsch E; Klak M; Wasik U; Milkiewicz M; Blatkiewicz M; Urasinska E; Barbier O; Bielicki D; Bogdanos DP; Elias E; Milkiewicz P
J Immunol Res; 2015; 2015():571353. PubMed ID: 26504856
[TBL] [Abstract][Full Text] [Related]
16. Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review.
Mago S; Wu GY
J Clin Transl Hepatol; 2020 Sep; 8(3):336-346. PubMed ID: 33083257
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the United Kingdom-primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population.
Alomari M; Covut F; Al Momani L; Chadalavada P; Hitawala A; Young MF; Romero-Marrero C
JGH Open; 2020 Apr; 4(2):132-139. PubMed ID: 32280755
[TBL] [Abstract][Full Text] [Related]
18. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
19. The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities.
Mazzetti M; Marconi G; Mancinelli M; Benedetti A; Marzioni M; Maroni L
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33919600
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Rust C; Beuers U
Clin Rev Allergy Immunol; 2005 Apr; 28(2):135-45. PubMed ID: 15879619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
